SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) – Trademark Portfolio
Entity Type: 11
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 26 (Fancy Goods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include WIGBOW. The owner is based in SHENZHEN.
INTERSECTION OF FUHUA RD. AND JINTIAN RD
SHENZHEN , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Frequently Asked Questions
How many trademarks does SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) have?
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) file in?
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) files trademarks across 1 Nice Classification class. The most active classes are Class 26 (Fancy Goods). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.
What are SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.)'s most well-known trademarks?
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.)'s registered trademark portfolio includes well-known marks such as WIGBOW. These are among 1 currently registered trademark in the portfolio.
What is SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.)'s trademark registration success rate?
SHENZHEN FANQI BIO-TECHNOLOGY LIMITED LIMITED COMPANY (LTD.) has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.